Skip to main content
. 2020 May 11;91(2):322–325. doi: 10.23750/abm.v91i2.8618

Table 6.

Pathological results of the re-TURBT

At second-look TURBT:
No cancer 47 (54,02%)
TaLG 6 (6,89%)
T1LG 14 (16,09%)
T1HG 17 (19,54%)
T2HG 3 (3,46%)